HTG Molecular Diagnostics, Inc. filed its 10-K on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, BDO LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0025 USD | +66.67% | 0.00% | +92.31% |
2023 | Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc. | CI |
2023 | Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
+92.31% | 5.54K | |
-12.00% | 19.08B | |
-45.14% | 2.65B | |
+18.15% | 1.87B | |
-3.12% | 1.61B | |
+25.65% | 1.21B | |
-10.69% | 1.02B | |
-20.89% | 905M | |
-5.01% | 716M | |
-17.39% | 682M |
- Stock Market
- Equities
- HTGMQ Stock
- News HTG Molecular Diagnostics, Inc.
- HTG Molecular Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt